Table 2.
Group 0.2% (n = 23) |
Group 0.4% (n = 27) |
|
---|---|---|
Age (yr) | 51 (28–57) | 44 (27–57) |
Sex (female/male) | 10/13 | 11/16 |
Height (cm) | 168 (162–178) | 168 (163–178) |
Weight (kg) | 75 (64–89) | 73 (65–95) |
Minimum current via | 0.49 (0.40–50) | 0.48 (0.44–0.50) |
needle (mA) | ||
Minimum current via | 0.45 (0.39–51) | 0.42 (0.30–0.51) |
catheter (mA) | ||
Subjects receiving an | 14 | 15 |
additional 20 mL | ||
mepivacaine bolus (#) | ||
Intraoperative | 3 (2–4) | 3 (2–4) |
midazolam (mg) | ||
Intraoperative fentanyl | 188 (50–200) | 125 (100–200) |
(µg) | ||
Intraoperative | 0 (0–0) | 0 (0–0) |
morphine (mg) | ||
Surgery duration (min) | 75 (60–115) | 75 (55–95) |
Subjects from site | 13/8/2 | 15/10/2 |
A/B/C (#) |
Values are reported as median (25th–75th percentiles) or number of subjects, as indicated. Applying statistics to preintervention variables for subjects randomized to treatment groups is inappropriate. For this reason, no statistical comparisons were applied to the data of this table.